CD4 and infection: Specifically, male, age over 30, heterosexual infection, long-term infection, CRF01_AE subtype, and pre-treatment CD4 T cell counts < 350/μL, clinical III and IV stage, and longer initiated treatment time were identified as risk factors impeding CD4+T lymphocyte recovery.